1. Home
  2. KTTA vs RDI Comparison

KTTA vs RDI Comparison

Compare KTTA & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.54

Market Cap

23.2M

Sector

Health Care

ML Signal

HOLD

RDI

Reading International Inc

HOLD

Current Price

$1.27

Market Cap

23.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTTA
RDI
Founded
2020
1937
Country
United States
United States
Employees
5
2005
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
23.2M
23.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KTTA
RDI
Price
$0.54
$1.27
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
436.1K
18.7K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$16.25
Revenue Next Year
N/A
$4.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.94
52 Week High
$2.06
$1.65

Technical Indicators

Market Signals
Indicator
KTTA
RDI
Relative Strength Index (RSI) 35.96 59.70
Support Level $0.49 $0.99
Resistance Level $0.76 $1.35
Average True Range (ATR) 0.05 0.07
MACD 0.00 0.01
Stochastic Oscillator 37.62 71.74

Price Performance

Historical Comparison
KTTA
RDI

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

Share on Social Networks: